Clinical Trials Logo
  1. Home
  2. Myocardial Infarction
  3. NCT03735134
  4. Details
NCT03735134 Clinical Trial

Colchicine in Periprocedural Myocardial Infarction: the Role of Alpha Defensin

Myocardial Infarction Clinical Trial

Official title:
Colchicine in Periprocedural Myocardial Infarction: the Role of Alpha Defensin

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT03735134
Other study ID # HYMC-99-18
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date November 2018
Est. completion date July 2020

Study information
Verified date November 2018
Source Hillel Yaffe Medical Center
Contact Rami Abu Fanne, MD, PhD
Phone 972-50-3573694
Email ramia@hadassah.org.il
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this research is to study the effect of a loading dose of colchicine on the occurrence of periprocedural myocardial infarction (PPMI) in elective percutaneous coronary intervention.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 180
Est. completion date July 2020
Est. primary completion date July 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Patients hospitalized with troponin negative events and scheduled for elective PCI

Exclusion Criteria:

- Significant renal dysfunction

- Significant liver dysfunction

- Severe left ventricular dysfunction

- Severe low weight

- Chronic colchicine treatment

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Colchicine Loading Dose
Two milligrams of colchicine will be administrated in addition to the standard of care treatment
• Standard of care treatment prior to elective PCI
All medications normally given to patients prior to elective PCI

Locations
Country Name City State
Israel Hille Yaffe Medical Center Hadera

Sponsors (1)
Lead Sponsor Collaborator
Hillel Yaffe Medical Center

Country where clinical trial is conducted

Israel, 

Outcome
Type Measure Description Time frame Safety issue
Primary Occurrence of PPMI post elective PCI Occurrence of PPMI post elective PCI and its relation to defensin levels 24 hours post PCI
Secondary Traditional inflammatory markers Determination of traditional inflammatory markers including c-reactive protein, white blood cells and interleukin-6 24 hours post PCI
Secondary Major adverse cardiovascular events Determining the occurrence of major adverse cardiovascular events 30 days
See also
  Status Clinical Trial Phase
Recruiting NCT06013813 - Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI N/A
Completed NCT04507529 - Peer-mentor Support for Older Vulnerable Myocardial Infarction Patients N/A
Recruiting NCT06066970 - Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery
Recruiting NCT03620266 - Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI N/A
Completed NCT04097912 - Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
Completed NCT04153006 - Comparison of Fingerstick Versus Venous Sample for Troponin I.
Completed NCT03668587 - Feasibility and Security of a Rapid Rule-out and rule-in Troponin Protocol in the Management of NSTEMI in an Emergency Departement
Recruiting NCT01218776 - International Survey of Acute Coronary Syndromes in Transitional Countries
Completed NCT03076801 - Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease? N/A
Recruiting NCT05371470 - Voice Analysis Technology to Detect and Manage Depression and Anxiety in Cardiac Rehabilitation N/A
Recruiting NCT04562272 - Attenuation of Post-infarct LV Remodeling by Mechanical Unloading Using Impella-CP N/A
Completed NCT04584645 - A Digital Flu Intervention for People With Cardiovascular Conditions N/A
Active, not recruiting NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Not yet recruiting NCT06007950 - Time-restricted Eating Study (TRES): Impacts on Anthropometric, Cardiometabolic and Cardiovascular Health N/A
Withdrawn NCT05327855 - Efficacy and Safety of OPL-0301 Compared to Placebo in Adults With Post-Myocardial Infarction (MI) Phase 2
Recruiting NCT02876952 - High Intensity Aerobic Interval Training With Mediterranean Diet Recommendations in Post-Myocardial Infarct Patients N/A
Completed NCT02711631 - Feasibility and Effectiveness of Remote Virtual Reality-Based Cardiac Rehabilitation N/A
Completed NCT02917213 - Imaging Silent Brain Infarct And Thrombosis in Acute Myocardial Infarction
Completed NCT02382731 - Interventions to Support Long-Term Adherence aNd Decrease Cardiovascular Events Post-Myocardial Infarction N/A
Completed NCT02305602 - A Study of VentriGel in Post-MI Patients Phase 1